<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe 2 adult patients with <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) who died from <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> following L-asparaginase treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Since this drug is known to cause a decrease in antithrombin III, the most important protein physiologically involved in the neutralization of thrombin, we studied the behaviour of this inhibitor in 14 ALL patients treated with a protocol including a 14-day course of L-asparaginase </plain></SENT>
<SENT sid="2" pm="."><plain>A significant but transient fall of biological and immunological antithrombin III and a concomitant reduction of fibrinogen were documented </plain></SENT>
</text></document>